Compound Evidence File
#EC-2026-0107
Deca (Nandrolone Decanoate)
Filed under Injectable Oils. The bureau holds 34 laboratory returns for this compound from 15 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
15 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| AKS ChemCASE #VI-2026-0313 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Feb 2025 | 13 Feb 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 9.9 | 9.9 | 9.9 | 7 May 2025 | 7 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.9 | 8.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.8 | 7.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.7 | 8.3 | 9.1 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.3 | 7.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.2 | 7.1 | 9.4 | 23 May 2026 | 23 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 7.9 | 7.9 | 7.9 | 9 Jun 2025 | 9 Jun 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 7.7 | 7.7 | 7.7 | 24 Apr 2025 | 24 Apr 2025 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 6.8 | 6.8 | 6.8 | 16 Mar 2025 | 16 Mar 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 5.9 | 5.9 | 5.9 | 16 Mar 2025 | 16 Mar 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 5.7 | 5.7 | 5.7 | 20 Jun 2025 | 20 Jun 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 1 | 5.2 | 5.2 | 5.2 | 9 Jun 2025 | 9 Jun 2025 |
Open any subject to view the batch-level evidence for Deca (Nandrolone Decanoate) alone.